]i transients and contraction with electrically stimulated adult rat cardiac myocytes. At a low concentration (10 ng/ml) TNF-␣ produced a 40% increase in the amplitude of both [Ca 2ϩ ]i transients and contraction within 40 min. At a high concentration (50 ng/ml) TNF-␣ evoked a biphasic effect comprising an initial positive effect peaking at 5 min, followed by a sustained negative effect leading to 50-40% decreases in [Ca 2ϩ ]i transients and contraction after 30 min. Both the positive and negative effects of TNF-␣ were reproduced by AA and blocked by arachidonyltrifluoromethyl ketone (AACOCF3), an inhibitor of cytosolic PLA2. Lipoxygenase and cyclooxygenase inhibitors reproduced the highdose effects of TNF-␣ and AA. The negative effects of TNF-␣ and AA were also reproduced by sphingosine and were abrogated by the ceramidase inhibitor n-oleoylethanolamine. These results point out the key role of the cytosolic PLA2/AA pathway in mediating the contractile effects of TNF-␣.
heart; cytosolic Ca 2ϩ -dependent phospholipase A2; ceramidase; sphingosine TUMOR NECROSIS FACTOR (TNF)-␣ is a proinflammatory cytokine with pleiotropic effects, initially described as a lipopolysaccharide (LPS)-induced macrophage product. Whereas there is no constitutive expression of the TNF-␣ gene in normal heart, TNF-␣ is produced by various cardiac cell types, including cardiomyocytes, in response to stressful stimuli (9, 16) . Several studies have shown a negative inotropic effect of TNF-␣ (1, 10, 11, 24, 26, 42) associated with alterations in Ca 2ϩ homeostasis (42) , sphingosine production (26) , and inducible nitric oxide synthase induction (1) . In animal models, whether administered by peritoneal infusion (3) or overexpressed by cardiomyocytes (4, 8, 18) , TNF-␣ causes severe heart dysfunction, the rate of progression and severity of which depend on the degree of TNF-␣ overexpression (8) . This is relevant to observations that, in human subjects, high levels of this circulating cytokine, and/or its high expression in the myocardium, are causally linked to the progression of dilated cardiomyopathy (12, 19, 30, 39) .
Contrary to these deleterious effects on heart contraction observed at high concentrations, Mann and collaborators (25) reported that, at low concentrations, TNF-␣ may have an important autocrine and/or paracrine homeostatic role in the heart. This is supported by the observations that TNF-␣ 1) protects against hypoxic injury (25) , 2) induces hypertrophic growth (41) , and 3) has a positive inotropic effect on heart contractility in conscious dogs (24) . The signaling pathways involved in the effects of TNF-␣ remain obscure.
In various cell types, including cardiomyocytes, TNF-␣ increases arachidonic acid (AA) release through phospholipase A 2 (PLA 2 ) activation (22) . AA is a major polyunsaturated fatty acid in cellular membranes. It plays a unique role relative to other fatty acids because it can be metabolized to various cardioactive compounds, including prostanoids via the cyclooxygenase (COX) pathway, leukotrienes via the lipoxygenase (LOX) pathway, and epoxyeicosatrienioic acids via the cytochrome P-450 pathway (for review, cf. Ref. 40) . AA itself can be a potent intracellular second messenger. In cardiomyocytes it modulates a variety of systems, including ion channels, gap junctions, and protein kinase C (PKC) activity (for review, cf. Ref. 28) . We previously demonstrated the role of AA as a second messenger in the positive effects of glucagon/miniglucagon (32, 33) and ␤ 2 -adrenergic agonists (23, 27) .
Although AA release induced by TNF-␣ has been linked to biological effects in other cell types, this question has not been specifically addressed in cardiomyocytes. Indeed, previous studies have examined either the effects of TNF-␣ on AA release, intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) transients, and/or cardiac function or those of AA on contraction and/or [Ca 2ϩ ] i transients (5, 13, 15, 27, 33) . The aim of the present study was to reproduce the effects of TNF-␣ on heart contraction, which were previously described in conscious dogs (24) and the perfused isolated heart (42), in isolated cardiomyocytes obtained from adult animals, to examine the possible role of AA as a trigger of TNF-␣-induced [Ca 2ϩ ] i transient and contractile responses.
METHODS
Cardiomyocyte isolation. Adult male Wistar rats weighing 180-250 g (Janvier, Le Genest St Isle, France) were used. Calcium-tolerant myocytes were isolated by cardiac retrograde aortic perfusion as described by Delcayre et al. (6) 3 H]AA. Briefly, freshly isolated cardiomyocytes were suspended in complete BM86 (BM86 Wissler medium supplemented with 100 IU/ml penicillin, 0.1 g/ml streptomycin, 4 g/ml insulin, 20 g/ml holotransferrin, and 1 mM glutamine), plated in 24-well plates previously coated with 3 g/ml laminin (10 5 rod-shaped cells/ well in 2 ml complete BM86), and left in humidified 5% CO 2-95% air at 37°C. After 2 h, the cell medium was replaced by 2 ml of complete BM86 with 1 Ci/ml [ 3 H]AA (4.5 nM). After 24-h incubation, cells were washed twice with 2 ml of complete BM86 with 0.2% fatty acid-free serum albumin, twice with 2 ml of HEPES buffer [in mM: 130 NaCl, 4.8 KCl, 1.2 KH 2PO4, 25 HEPES, pH 7.4, 5 D(ϩ)-glucose] with 0.2% fatty acid-free serum albumin, and once with 2 ml of HEPES buffer. When stated, [ 3 H]AA-labeled cardiomyocytes were preincubated for 15 min with or without 10 M arachidonyltrifluoromethyl ketone (AACOCF3). At time 0 of the experiment, cells were exposed to TNF-␣ or vehicle for 10 or 20 min at 37°C. Incubation was terminated by the addition of ice-cold EGTA (4 mM final), and cell medium was immediately transferred to microcentrifuge tubes. After centrifugation at 17,600 g for 20 min at 4°C, the amount of radioactivity in the supernatants was quantitated by liquid scintillation counting.
Measurement of [Ca 2ϩ ]i transients and cell fractional shortening. Freshly isolated cardiomyocytes were plated on plastic dishes, on the bottom of which was placed a glass coverslip coated with 2 g/ml laminin (10 5 rod-shaped cells/ dish in 2 ml HEPES buffer containing 2% bovine serum albumin), and were incubated at 37°C in humidified 5% CO 2-95% air for 1.5-3 h. Cells, attached to laminin, were bathed in 2 ml of saline buffer A (in mM: 10 glucose, 130 NaCl, 5 KCl, 10 HEPES buffered at pH 7.4 with Tris base, 1 MgCl 2, 2 CaCl2) and were incubated for 20 min at 25°C with 1.5 M fura 2-AM in the presence of 0.1% bovine serum albumin to improve fura 2 dispersion and facilitate cell loading. Cells were then washed twice with saline buffer A. Field electrical stimulation (square waves, 10-ms duration, 0.5 Hz) was supplied through a pair of platinum electrodes connected to the output of a HAMEG stimulator (Paris, France). Ca shortening was determined from the fluorescence images recorded to measure F 360/F380 with Scion Image software (Scion, Frederick, MD). All tracings of fluorescence ratios and fractional shortenings are representative of 6-10 cells obtained from three different isolations.
Statistical analysis. Data are expressed as means Ϯ SE. Results were analyzed by using Student's two-tailed t-test or repeated-measures ANOVA and post hoc multiple-comparison testing between control and treatment groups (Dunnett's test), as appropriate. Differences were considered statistically significant at P Ͻ 0.05.
RESULTS

TNF-␣ exerts dual effect on [Ca 2ϩ
] i transients and contraction in electrically stimulated adult rat ventricular myocytes. Perfusion of electrically stimulated cardiomyocytes with TNF-␣ for 40 min produced a concentration-dependent dual effect on [Ca 2ϩ ] i transients ( Fig. 1) . At a low concentration (10 ng/ml), TNF-␣ produced an overall 32 Ϯ 10% increase over control in amplitude of [Ca 2ϩ ] i transients (taking into account all cells). In contrast, at a high concentration (50 ng/ml), TNF-␣ caused a 40 Ϯ 10% reduction in the amplitude of [Ca 2ϩ ] i transients relative to control (taking into account all cells).
As shown in Fig. 2A , 9 of 11 cardiomyocytes were responsive to a low concentration (10 ng/ml) of TNF-␣. Parallel, progressive increases in the amplitudes of [Ca 2ϩ ] i transients and contraction were observed (40 Ϯ 10% over control after 30 min) (Fig. 2) . At 50 ng/ml, in only 10 of 42 cells tested, TNF-␣ produced a positive effect similar to that observed with a low concentration of TNF-␣ (ϩ40 Ϯ 10% in the amplitude of [Ca 2ϩ ] i transients and contraction after 40 min; not shown), and in 7 cells it produced a transitory positive response (ϩ20 Ϯ 10% increases in both [Ca 2ϩ ] i transients and contraction at 5 min; not shown). However, principally, TNF-␣ had a biphasic effect in 25 of 42 cells, consisting of an early stimulating effect on both [Ca 2ϩ ] i transients and contraction (ϩ20-30%, respectively, at 5 min) followed by a time-dependent depressant effect (Fig. 3A) . After 30-40 min of perfusion, the amplitude of [Ca 2ϩ ] i transients was only 50-30% of its initial value and was accompanied by a 40-50% decrease in the amplitude of cell contraction (Fig. 3) . Importantly, washing with buffer during the following 30 min achieved a return of [Ca 2ϩ ] i transients and contraction amplitudes to baseline values (Fig. 3B) . The typical traces of [Ca 2ϩ ] i transients and cell fractional shortening in Figs. 2B and 3B illustrate the correlation between the increases and decreases in [Ca 2ϩ ] i cycling and contraction. Those overall observations are consistent with the biphasic effect of TNF-␣ previously described in conscious dogs (24) . They further suggest that the overall effect of high concentrations of TNF-␣ on [Ca 2ϩ ] i transients and contraction is the result of both a positive and a negative effect. The positive effect occurs earlier than the negative effect and in response to lower concentrations of TNF-␣. After 5 min, the negative effect develops, and it attenuates, neutralizes, or dominates the positive effect, resulting in sustained positive, transitory posi- tive, or biphasic responses, respectively. The balance between the two effects can be due to different metabolic states of the cells (see DISCUSSION) . It should be noted that the biphasic effect was not related to deterioration in cell viability of some cardiomyocytes. In fact, all the cardiomyocytes responded to electrical stimulation over the entire time of the experiments, which could be taken as an index of cell integrity. Also, as an additional control, we checked that all the cells that contracted in response to electrical stimulation excluded trypan blue. (Fig. 4A) . Thus, to assess the possible involvement of the cPLA 2 /AA pathway in the effects of TNF-␣ on [Ca 2ϩ ] i transients and contraction, we examined the effect of AACOCF3 in electrically stimulated cardiomyocytes. AACOCF3 (10 M) had no effect by itself but abrogated both the positive and negative effects of 10 and 50 ng/ml TNF-␣, respectively, on [Ca 2ϩ ] i transients and contraction (Fig. 4B) .
AA reproduces dual effect of TNF-␣ on [Ca 2ϩ ] i transients and contraction in electrically stimulated cardiomyocytes. The time-dependent effect of increasing concentrations of AA added to the perfusion medium on [Ca 2ϩ ] i transients of electrically stimulated adult rat cardiomyocytes was examined next (Fig. 5) . AA concentrations up to 3 M had no significant effect (Fig. 5A) . With 5 M AA (Fig. 5B ) a sustained increase in the amplitude of [Ca 2ϩ ] i transients and contraction was observed in 6 of 11 cells (ϩ30-40% after 20 min), whereas a transitory increase occurred in 1 cell (ϩ20-25% at 5 min) and a biphasic effect was observed in 4 cells (10-20% activation at 5 min followed by a progressive depression reaching 40-50% below control values at 30 min). As shown in cells responded in a biphasic way (15-20% activation at 5 min followed by a progressive depression reaching 40-50% below control values at 30 min). At the highest concentration of AA tested (25 M), half of the cells displayed a transitory positive response (ϩ10-15% at 5 min) whereas the other half of the cells displayed a biphasic response (ϩ15-20% at 5 min followed by a progressive depression reaching 50-60% below control values at 30 min). The typical traces of [Ca 2ϩ ] i transients and cell fractional shortening in Fig. 6 further illustrate the correlation between the increases and decreases in [Ca 2ϩ ] i transients and contraction. It should be noted that AACOCF3, when added to the cell medium 15 min before AA, affected neither the positive nor the negative effect of AA at 10 and 25 M, respectively.
Inhibitors of LOX and COX, the two main pathways of AA metabolism in cardiomyocytes, are thought to increase AA accumulation. Thus we examined the effect of baicalein (25 M), a 12-LOX inhibitor, and that of ibuprofen (50 M), a COX inhibitor. The latter was preferred to indomethacin, which is reported to inhibit PLA 2 (34) . The LOX and COX inhibitors reproduced the biphasic effect observed with high AA and TNF-␣ concentrations on [Ca 2ϩ ] i transients and contraction: in all cells, at 5 min baicalein and ibuprofen produced a mean 20 Ϯ 5% increase (P Ͻ 0.05; not shown) in the amplitude of both [Ca 2ϩ ] i transients and contraction, followed in the majority of the cells (50% and 81%, respectively) by a depressant effect. As shown in Fig. 7 , ibuprofen was somewhat more efficient than baicalein to produce the negative effect (Ϫ43 Ϯ 16% vs. Ϫ23 Ϯ 8% in [Ca 2ϩ ] i cycling and Ϫ32 Ϯ 8% vs. Ϫ21 Ϯ 8% in contraction, respectively, after 30 min). The combined effects of the two inhibitors equaled that of ibuprofen alone. These results suggested that the negative effects of AA and TNF-␣ were due to the action of AA itself, rather than a metabolic product.
Negative effects of TNF-␣ and AA on [Ca 2ϩ ] i transients and cardiomyocyte contractility require ceramidase activation. It has been reported that sphingosine mediates the negative inotropic effect of TNF-␣ on adult feline cardiac myocytes (26) . As shown in Fig. 8 , within 30 min, exogenous sphingosine exerted a dosedependent depressant effect on [Ca 2ϩ ] i transients and contraction: 1 M sphingosine elicited 25 Ϯ 4% and 28 Ϯ 5% inhibition, respectively, whereas 10 M sphingosine produced a total inhibition of both [Ca 2ϩ ] i transients and contraction in six of seven cells, thus mimicking the negative effects of 25 M AA and 50 ng/ml TNF-␣. We next examined whether n-oleoylethanolamine (NOE), a specific ceramidase inhibitor that converts ceramide to sphingosine, could abrogate the effects of TNF-␣ and AA on [Ca 2ϩ ] i transients and contraction. Cardiomyocytes were preincubated for 30 min with buffer, with or without 1 M NOE, and exposed thereafter for 30 min to 50 ng/ml TNF-␣ or 25 M AA, added in combination with or without 1 M NOE. As shown in Fig. 8 , treatment with NOE abrogated the global negative effects of both 25 M AA and 50 ng/ml TNF-␣ on [Ca 2ϩ ] i transients and cell contrac- tion. An important finding was that NOE unmasked the positive effects on [Ca 2ϩ ] i transients and contraction of 25 M AA and 50 ng/ml TNF-␣. In the presence of NOE, 40% and 50% of the cells responded positively to 25 M AA and 50 ng/ml TNF-␣, respectively. It should also be noted that NOE, by itself, had a statistically significant positive effect on the amplitude of [Ca 2ϩ ] i transients and contraction: 34 Ϯ 7% and 30 Ϯ 7%, respectively (P Ͻ 0.05; Fig. 8 ). An attractive explanation is that, in control conditions, because of ceramidase activity, sphingosine is produced in a quantity large enough to exert a negative constraint on [Ca 2ϩ ] i transients and contraction, which is relieved on inhibition of ceramidase. ] i transients in electrically stimulated adult rat cardiomyocytes. In fact, the dual action of AA observed in the present study is particularly reminiscent of that described by Kang and Leaf (15) . These authors reported that perfusion of spontaneously beating neonatal rat cardiomyocytes with 5-10 M AA had different effects on the rate of contraction (increase, decrease, or no change) and proposed that differences in the individual sensitivity of cardiomyocytes to AA could be due to differences in lipid metabolic status.
TNF-␣ is produced by the heart in cardiac pathophysiological contexts (2, 35, 38) . However, only concentrations of TNF-␣ in the plasma (3-9 ng/ml) have been determined (2, 7, 37) , and according to TorreAmione et al. (37) , there is no tight correlation between those concentrations and the cytokine levels in heart tissue. Thus we examined the effect of TNF-␣ on isolated cardiomyocytes at concentrations ranging from 2.5 to 50 ng/ml, similar to those used in different studies that dealt with various effects of TNF-␣ in isolated cardiomyocytes: the effects of TNF-␣ on hypoxic injury and on the hypertrophic growth response in isolated adult feline cardiomyocytes were examined at 10-1,000 U/ml, i.e., 0.5-50 ng/ml (25, 41) , activation of PLA 2 was examined with 2.5-50 ng/ml (22) , and the apoptotic effect was examined with Յ4,000 U/ml, i.e., 90 ng/ml TNF-␣ concentrations (17) . The use of such concentrations is compatible with the dissociation constant (K d ) of TNF-␣ receptors: 0.3 nM, i.e., 5 ng/ml (38) .
The depressant effect triggered by high concentrations of either AA or TNF-␣ observed here is reproduced by inhibitors of the AA metabolic pathways, LOX and COX. This suggests that AA itself, rather than a metabolic product, was involved in this effect. In addition, we show that the depressant effects of TNF-␣ and AA are reproduced by treating cardiomyocytes with 1-10 M sphingosine. Conversely, they are blocked by NOE, a specific inhibitor of ceramidase that converts ceramide to sphingosine. Those findings are in agreement with the previous statement that, in adult cardiomyocytes, sphingosine mediated the negative contractile effect of TNF-␣ and designate the target of AA upstream of sphingosine generation. Ceramidase has not been identified as a target for AA. In contrast, the neutral sphingomyelinase, which converts sphingomyelin to ceramide, is activated by AA (14, 29) and therefore represents an attractive candidate.
We show here that the positive contractile effects of AA and TNF-␣ are largely favored in blockade of the ceramidase pathway. The question as to whether the positive effect of AA on [Ca 2ϩ ] i transients and contraction is mediated by AA itself or by metabolites has been answered by a previous study that focused on the positive effect of AA (5, 22) . Those authors concluded that the positive effect of AA on [Ca 2ϩ ] i transients and contraction was mediated partly by AA itself and in part by COX metabolites and would involve PKC-dependent inhibition of voltage-gated K ϩ channels. In previous studies (23, 33) , we also showed that AA causes Ca 2ϩ accumulation in the sarcoplasmic compartment sensitive to caffeine, a mechanism likely to support positive inotropy.
Thus, to summarize, the effects of AA on [Ca 2ϩ ] i transients and contraction combine 1) a positive effect predominating at low AA concentrations and 2) a negative effect that prevails with increasing AA concentrations. The relative activation of the positive and negative pathways determines the nature of the final response.
The negative contractile effect of TNF-␣ is one of its major pathogenic effects. The present study identifies AA as a mediator of this effect, presumably upstream of the ceramidase cycle. Future studies will be designed to evaluate the possible role of the neutral sphingomyelinase as the target of AA (14) . Interestingly, Liu and Hannun and coworkers (20, 21) showed that physiological levels of glutathione inhibit the neutral sphingomyelinase activity. Thus one can speculate that the cellular level of glutathione is a determinant component in the contractile response to TNF-␣. Additional studies are required to determine whether manipulating intracellular glutathione levels affects the response of isolated cardiomyocytes to AA and TNF-␣ and whether this extends to the whole heart in the animal. It should be noted that variations in the cellular glutathione levels of isolated cardiomyocytes could underlie the divergence of cell responses observed in the present study.
In conclusion, our results show that the positive and negative effects of TNF-␣ on heart contraction are mediated by cPLA 2 activation and AA release. Although short-term effects in isolated cells cannot be directly extrapolated to long-term phenomena occurring in the heart in vivo, this study also raises the possibility that cPLA 2 activation and AA may be major pathogenic and/or protective components of heart functioning depending on the oxidative and metabolic status of the cardiomyocytes.
